Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.5000
0.00 (0.00%)
Oct 1, 2026, 4:10 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 123.8 million as of October 1, 2026. Its market cap has increased by 69.90% in one year.
Market Cap
123.80M
Enterprise Value
115.41M
Revenue
2.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
ChartMarket Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 123.80M, an increase of 381.60%. That is a compound annual growth rate of 26.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 123.80M | -54.56% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 215.48M |
| Orthocell | 208.33M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 138.09M |
| Island Pharmaceuticals | 108.01M |
| Recce Pharmaceuticals | 99.38M |
| Alterity Therapeutics | 88.83M |
| LTR Pharma | 87.25M |